Does CLADRIBINE Cause Mobility decreased? 48 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 48 reports of Mobility decreased have been filed in association with CLADRIBINE (Cladribine). This represents 0.6% of all adverse event reports for CLADRIBINE.
48
Reports of Mobility decreased with CLADRIBINE
0.6%
of all CLADRIBINE reports
0
Deaths
22
Hospitalizations
How Dangerous Is Mobility decreased From CLADRIBINE?
Of the 48 reports, 22 (45.8%) required hospitalization, and 2 (4.2%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CLADRIBINE. However, 48 reports have been filed with the FAERS database.
What Other Side Effects Does CLADRIBINE Cause?
Fatigue (696)
Headache (579)
Lymphocyte count decreased (448)
Multiple sclerosis relapse (404)
Nausea (354)
Pneumonia (318)
White blood cell count decreased (311)
Urinary tract infection (242)
Pyrexia (207)
Multiple sclerosis (206)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which CLADRIBINE Alternatives Have Lower Mobility decreased Risk?
CLADRIBINE vs CLARAVIS
CLADRIBINE vs CLARITHROMYCIN
CLADRIBINE vs CLARITIN
CLADRIBINE vs CLARITIN CHEWABLE
CLADRIBINE vs CLARITIN-D-12